VISHEE(SH:688580)2022-04-27 16:00Financial Performance - The total revenue for Q1 2022 was CNY 54,107,297.63, representing a year-on-year decrease of 32.53%[5] - The net profit attributable to shareholders was CNY 17,009,682.26, down 45.62% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 9,101,425.65, a decline of 64.88% year-on-year[5] - Basic earnings per share were CNY 0.2489, down 45.62% year-on-year[6] - Total operating revenue for Q1 2022 was ¥54,107,297.63, a decrease of 32.5% compared to ¥80,199,797.02 in Q1 2021[20] - Net profit for Q1 2022 was ¥17,009,682.26, a decline of 45.0% from ¥31,143,408.53 in Q1 2021[21] - Basic earnings per share for Q1 2022 were ¥0.2489, compared to ¥0.4577 in Q1 2021, reflecting a decrease of 45.6%[22] Cash Flow - The cash flow from operating activities was negative at CNY -4,026,720.88, reflecting a decrease of 165.22%[6] - Cash inflow from operating activities in Q1 2022 was ¥80,426,045.90, down 10.6% from ¥89,860,727.29 in Q1 2021[23] - The net cash flow from operating activities was -$4,026,720.88, a decrease compared to $6,173,884.92 in the previous year[24] - Total cash outflow from operating activities was $84,452,766.78, slightly higher than $83,686,842.37 in the previous year[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,633,238,657.53, a slight decrease of 0.34% from the end of the previous year[6] - As of March 31, 2022, the total current assets amounted to ¥1,420,724,782.34, a slight decrease from ¥1,434,334,932.56 at the end of 2021, reflecting a change of approximately -0.95%[16] - The total liabilities as of Q1 2022 were ¥81,056,182.35, down 23.4% from ¥105,679,873.40 in Q1 2021[20] - Current liabilities increased, with accounts payable rising to ¥9,547,293.70 from ¥9,279,529.62, an increase of approximately 2.9%[17] Research and Development - Research and development expenses totaled CNY 15,816,919.49, which is 29.23% of total revenue, an increase of 16.39 percentage points[6] - Research and development expenses for Q1 2022 were ¥12,926,343.65, an increase of 25.5% from ¥10,297,726.89 in Q1 2021[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,761[13] - The largest shareholder, Wang Zhiyu, holds 39.45% of the shares, totaling 26,961,547 shares[13] Other Information - The company implemented a restricted stock incentive plan, resulting in a post-tax share-based payment expense of CNY 3,954,600[7] - The company has ongoing investments in new technologies and product development, although specific figures were not disclosed in the report[15] - There are no significant changes in the shareholder structure or any new mergers and acquisitions reported during the quarter[15] - The company did not report any new product launches or significant market expansions during this quarter[24] - The company is not applying the new accounting standards for the current year[25]